Evidence map›Paper›PMID 42254880›Full record

ArticlePulmonary circulation2026

Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension.

Teresa Segura de la Cal, Carmen Pérez-Olivares, Raquel Luna-López, Irene Martín de Miguel, Alejandro Cruz-Utrilla, Olga Villar, Fernando Sarnago, Pedro Muñoz, Marina Santiago Sánchez, María Jesús López Gude and 5 more

Abstract read
In one paragraph

Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Teresa Segura de la CalAdult Congenital Heart Disease Unit and Pulmonary Hypertension Unit, Department of Cardiology. ERN-Lung (European Reference Network on Rare Respiratory Diseases) Hospital Universitario 12 de Octubre Madrid Spain.ORCID https://orcid.org/0000-0003-0269-5574
Carmen Pérez-OlivaresDepartment of Cardiology Henares University Hospital Coslada Spain.
Raquel Luna-LópezDepartment of Cardiology of Hospital Clinic and Hospital Sant Joan de Deu, Hospital Clinic Barcelona Hospital Sant Joan de Deu Barcelona Spain.ORCID https://orcid.org/0000-0002-1842-929X
Irene Martín de MiguelAdult Congenital Heart Disease Unit and Pulmonary Hypertension Unit, Department of Cardiology. ERN-Lung (European Reference Network on Rare Respiratory Diseases) Hospital Universitario 12 de Octubre Madrid Spain.
Alejandro Cruz-UtrillaPulmonary Hypertension Unit, Department of Cardiology. ERN-LUNG (European Reference Network on Rare Respiratory Diseases). CIBERCV (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) Hospital Universitario 12 de Octubre Madrid Spain.ORCID https://orcid.org/0000-0002-3851-4037
Olga VillarDepartment of Obstetrics and Gynecology Hospital Universitario 12 de Octubre Madrid Spain.
Fernando SarnagoAdult Congenital Heart Disease Unit, Department of Cardiology Hospital Universitario 12 de Octubre Madrid Spain.
Pedro MuñozDepartment of Anaesthesiology Hospital Universitario 12 de Octubre Madrid Spain.
Marina Santiago SánchezDepartment of Anaesthesiology Hospital Universitario 12 de Octubre Madrid Spain.
María Jesús López GudeDepartment of Cardiac Surgery Hospital Universitario 12 de Octubre Madrid Spain.
Maite VelázquezCardiology Department and CIBERCV (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) Hospital Universitario 12 de Octubre Madrid Spain.
Laura ForcénDepartment of Obstetrics and Gynecology Hospital Universitario 12 de Octubre Madrid Spain.
Juan F DelgadoHeart Failure and Heart Transplant Unit, Department of Cardiology, and CIBERCV (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) Hospital Universitario 12 de Octubre Madrid Spain.
Fernando Arribas YnsaurriagaCardiology Department and CIBERCV (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) Hospital Universitario 12 de Octubre Madrid Spain.
Pilar Escribano-SubiasPulmonary Hypertension Unit, Department of Cardiology. ERN-LUNG (European Reference Network on Rare Respiratory Diseases). CIBERCV (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) Hospital Universitario 12 de Octubre Madrid Spain.ORCID https://orcid.org/0000-0002-6640-4839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy poses substantial risks for women with Pulmonary Arterial Hypertension (PAH). This study aimed to evaluate maternal and neonatal outcomes in a contemporary PAH cohort under modern management, specifically investigating whether vasoreactive status warrants distinct clinical recommendations. We conducted a retrospective, longitudinal cohort study of PAH pregnancies managed at our institution between February 2010 and December 2023, comparing clinical characteristics, maternal complications, long-term outcomes, and neonatal parameters between vasoreactive and non-vasoreactive patients. Among 29 patients, 8 underwent pregnancy termination, and 21 proceeded with the pregnancy; 7 (33.3%) of whom were vasoreactive. Non-vasoreactive patients experienced significantly higher rates of major complications (35.7% vs. 0%,

Indexed as

calcium channel blockersoffspringpregnancypulmonary arterial hypertensionvasoreactive

Identifiers

PMID42254880
PMCPMC13239620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.